Fact CheckerSign in

NCT05751252CompletedEarly phase 1

Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS.

Short-term GnRH- Antagonist Treatment to Lower LH Pulsatility in Women With PCOS Aiming to Improve Hormonal Functions

Source: ClinicalTrials.gov · Last updated 27 Apr 2025

Brief summary (registry, in English)

The clinical study using a sub-therapeutic dose of a GnRH antagonist to reduce overactive LH pulsatility in women with PCOS. With the intervention and lowered LH action we anticipate to decrease androgen levels in women with PCOS. The aim to show for the first time that low-dose GnRH-antagonists can lower LH pulsatility by 20-30% and decrease androgen levels without blunting the hypothalamic-pituitary-gonadal axis and thereby the reproductive functions.

Status (registry)
Completed
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
20 (actual)
First submitted
20 Feb 2023
Start date
17 Apr 2024
Primary completion date
9 Feb 2025
Lead sponsor
University Hospital, Lille
NCT number
NCT05751252
EudraCT number
2023-000176-35

What you commit to

  • Study type: Interventional · Early phase 1
  • Participants enrolled: 20
  • From 17 Apr 2024 to the primary completion date, 9 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • hormonal treatment or hormonal contraception
  • Metformin treatment
  • pregnant woman
  • inability to understand the newsletter

Who the study is looking for

  • Minimum weight of 51 kg
  • BMI between 20 and 25
  • women with PCOS with AMH\> 28 pmol / L, LH\> 8 IU / mL and testosteronemia \> 0.39 ng/mL
  • no hormonal treatment or contraception for 2 months
  • women covered by the Social Security system

Age in the registry: 18 years to 35 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Jeanne de Flandre
Coordinator of this site? Confirm its status
LilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.